ORBIMED ADVISORS LLC 13D and 13G filings for Verastem, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 5:56 pm Sale | 2025-06-30 | 13G | Verastem, Inc. VSTM | ORBIMED ADVISORS LLC | 1,333,333 2.400% | -1,529,115 (-53.42%) | Filing |
| 2025-05-15 6:41 pm Sale | 2025-03-31 | 13G | Verastem, Inc. VSTM | ORBIMED ADVISORS LLC | 2,862,448 5.600% | -1,286,414 (-31.01%) | Filing |
| 2024-11-14 6:25 pm Purchase | 2024-09-30 | 13G | Verastem, Inc. VSTM | ORBIMED ADVISORS LLC | 4,148,862 9.900% | 2,619,747 (+171.32%) | Filing |
| 2024-02-14 7:31 pm Purchase | 2023-12-31 | 13G | Verastem, Inc. VSTM | ORBIMED ADVISORS LLC | 1,529,115 6.100% | 1,529,115 (New Position) | Filing |